Helen Leonard

Dr. Helen Leonard

Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, Perth, WA 6872, Australia
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2017 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
AGAPSU Rare Diseases Impacts on Families Study group
APSU Rare Diseases Impacts on Families Study group
YZYvonne Zurynski
Yvonne Zurynski
MDMarie Deverell
Marie Deverell
TDTroy Dalkeith
Troy Dalkeith
SJSandra Johnson
Sandra Johnson
EEElizabeth Elliott
Elizabeth Elliott
Children and families living with rare disease often experience significant health, psychosocial, economic burdens and diagnostic delays. Experiences appear to be constant, regardless of the specific rare disease diagnosis. Systematically collected Australian data to support policy response on rare diseases are scarce. We address this gap by providing survey results about 462 children aged <19 years living with approximately 200 different rare diseases. Of 462 children, 96% were born in Australia, 55% were male, median age was 8.9 years (0–18.2). Four-hundred-and-twenty-eight (93%) had received a definitive diagnosis but 29 (7%) remained undiagnosed. Before receiving the correct diagnosis 38% consulted ≥ 6 different doctors. Among those with a diagnosis, 37% believed the diagnosis was delayed and 27% initially received a wrong diagnosis. Consequences of delayed diagnosis include anxiety, loss of reproductive confidence because of an ill-defined genetic risk, frustration and stress (54%), disease progression (37%), delays in treatment (25%) and inappropriate treatments (10%). Perceived reasons for diagnostic delays included lack of knowledge about the disease among health professionals (69.2%), lack of symptom awareness by the family (21.2%) and difficulties accessing tests (17.9%). Children with inborn errors of metabolism were less likely to have a delayed diagnosis compared with other disease groups (Chi-Sq = 17.1; P < 0.0001), most likely due to well-established and accessible biochemical screening processes. Diagnosis was given in person in 74% of cases, telephone in 18.5% and via a letter in 3.5%. Some families (16%) were dissatisfied with the way the diagnosis was delivered, citing lack of empathy and lack of information from health professionals. Psychological support at diagnosis was provided to 47.5%, but 86.2% believed that it should always be provided. Although 74.9% of parents believed that the diagnosis could have an impact on future family planning, only 44.8% received genetic counselling. Parents of children living with rare chronic and complex diseases have called for better education, resourcing of health professionals to prevent avoidable diagnostic delays, and to facilitate access to early interventions and treatments. Access to psychological support and genetic counselling should be available to all parents receiving a life-changing diagnosis for their child.

25 April 2022 in The Lancet Neurology
Verified
Journal Article
Closed access
HLHelen Leonard
Helen Leonard
JDJenny Downs
Jenny Downs
TBTim A Benke
Tim A Benke
LSLindsay Swanson
Lindsay Swanson
HOHeather Olson
Heather Olson
SDScott Demarest
Scott Demarest

19 June 2014 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
AAAlison Anderson
Alison Anderson
KWKingsley Wong
Kingsley Wong
PJPeter Jacoby
Peter Jacoby
JDJenny Downs
Jenny Downs
HLHelen Leonard
Helen Leonard
The clinical characteristics of children diagnosed with Rett syndrome are well described. Survival and how these characteristics persist or change in adulthood are less well documented. This study aimed to describe overall survival and adult health in those with Rett syndrome.

1 September 2011 in Pediatric Research
Verified
Journal Article
Open access
PDF file
SFStephanie Fehr
Stephanie Fehr
ABAmi Bebbington
Ami Bebbington
Nashaat NassarNashaat Nassar
Nashaat Nassar
JDJenny Downs
Jenny Downs
GRGabriel M Ronen
Gabriel M Ronen
HLHelen Leonard
Helen Leonard
Modifications to diagnostic criteria and introduction of genetic testing have likely affected the pattern and timing of Rett syndrome diagnosis. The trends in incidence and prevalence of Rett syndrome in Australia were examined; the cumulative risk of a female being diagnosed was determined; and the impact of changes to diagnostic criteria and availability of genetic testing on these frequencies was investigated. The population-based Australian Rett Syndrome Database was used to identify a total of 349 verified Rett syndrome females born 1976–2006 and diagnosed 1982–2008. The proportion of female cases born and diagnosed per year and the cumulative risk of a diagnosis were determined. The median age of Rett syndrome diagnosis decreased from 4.5 y if diagnosed before 2000 to 3.5 y if diagnosed after 1999. The cumulative risk of diagnosis had almost doubled by 32 y of age [1/8,905 or 11.23 per 100,000 person-years (95% CI, 10.03–12.45)] in comparison with 5 y of age [1/15,361 or 6.51 per 100,000 person-years (95% CI, 5.65–7.39)]. Earlier age of diagnosis may result in families experiencing less stress and emotional strain compared with those with delayed diagnosis.

7 September 2009 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
Nashaat NassarNashaat Nassar
Nashaat Nassar
GDGlenys Dixon
Glenys Dixon
JBJenny Bourke
Jenny Bourke
CBCarol Bower
Carol Bower
EGEmma Glasson
Emma Glasson
HLHelen Leonard
Helen Leonard
Background It is unclear whether the increase in autism over the past two decades is a real increase or due to changes in diagnosis and ascertainment of autism spectrum disorders (ASDs), which include autism, Asperger syndrome and pervasive developmental disorder not otherwise specified (PDD-NOS). The aim of this study was to examine the trends in ASD over time in Western Australia (WA) and the possible effects and contribution of changes in diagnostic criteria, age at diagnosis, eligibility for service provision based on ASD diagnoses and changes in diagnostic practices. Methods A population-based study was conducted among the cohort of children born in WA between 1983 and 1999 and diagnosed with ASD between the age of 2 and 8 years up to December 31, 2004. The trend in ASD diagnosis over the study period was assessed by investigating birth cohort and period effects, and examining whether these were modified by age of diagnosis. ASD diagnosis corresponding with changes in diagnostic criteria, funding and service provision over time were also investigated. A subgroup analysis of children aged ≤5 years was also conducted to examine trends in the incidence and age of diagnosis of ASD and intellectual disability (ID) and to investigate the role of changes in diagnostic practices. Results The overall prevalence of ASD among children born between 1983 and 1999 and diagnosed by age 8 was 30 per 10 000 births with the prevalence of autism comprising 21 per 10 000 births. The prevalence of ASD increased by 11.9% per annum, from 8 cases per 10 000 births in 1983 to 46 cases per 10 000 births in 1999. The annual incidence of ASD, based on newly diagnosed ASD cases in each year from 1985 to 2002, increased over the study period. The increase in incidence of ASD appeared to coincide with changes in diagnostic criteria and availability of funding and services in WA, particularly for children aged <5 years. The age-specific rates of autism and PDD-NOS increased over time and the median age of diagnosis for autism decreased from 4 to 3 years of age throughout the 1990s. For children aged ≤5 years the incidence of ASD diagnosis increased significantly from 1992, with an average annual increase of 22%. Similar findings were found for autism. In the corresponding years the incidence of diagnosis of severe ID fell by 10% per annum and mild–moderate ID increased by 3% per annum. Conclusions The rise in incidence of all types of ASDs by year of diagnosis appears to be related to changes in diagnostic and service provision practices in WA. In children aged ≤5 years, diagnosis of severe ID decreased, but mild–moderate ID increased during the study period. A true increase in ASD cannot be ruled out.

30 March 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HLHelen Leonard
Helen Leonard
EGEmma Glasson
Emma Glasson
Nashaat NassarNashaat Nassar
Nashaat Nassar
AWAndrew Whitehouse
Andrew Whitehouse
ABAmi Bebbington
Ami Bebbington
FSFiona Stanley
Fiona Stanley
Research findings investigating the sociodemographics of autism spectrum disorder (ASD) have been inconsistent and rarely considered the presence of intellectual disability (ID). We used population data on Western Australian singletons born from 1984 to 1999 (n = 398,353) to examine the sociodemographic characteristics of children diagnosed with ASD with or without ID, or ID without ASD compared with non-affected children. The profiles for the four categories examined, mild-moderate ID, severe ID, ASD without ID and ASD with ID varied considerably and we often identified a gradient effect where the risk factors for mild-moderate ID and ASD without ID were at opposite extremes while those for ASD with ID were intermediary. This was demonstrated clearly with increased odds of ASD without ID amongst older mothers aged 35 years and over (odds ratio (OR) = 1.69 [CI: 1.18, 2.43]), first born infants (OR = 2.78; [CI: 1.67, 4.54]), male infants (OR = 6.57 [CI: 4.87, 8.87]) and increasing socioeconomic advantage. In contrast, mild-moderate ID was associated with younger mothers aged less than 20 years (OR = 1.88 [CI: 1.57, 2.25]), paternal age greater than 40 years (OR = 1.59 [CI: 1.36, 1.86]), Australian-born and Aboriginal mothers (OR = 1.60 [CI: 1.41, 1.82]), increasing birth order and increasing social disadvantage (OR = 2.56 [CI: 2.27, 2.97]). Mothers of infants residing in regional or remote areas had consistently lower risk of ASD or ID and may be linked to reduced access to services or under-ascertainment rather than a protective effect of location. The different risk profiles observed between groups may be related to aetiological differences or ascertainment factors or both. Untangling these pathways is challenging but an urgent public health priority in view of the supposed autism epidemic.